In November of 2023, Eli Lilly won FDA approval to sell tirzepatide as a weight-loss drug, soon-to-be marketed under the brand name Zepbound
However, supplements aren't tested by the FDA before they're sold, so use caution when you buy and use peptide supplements
Once approved, trained medical professionals like those at Leva Medical in Queens, NY may begin offering it as part of supervised weight-management programs
Berry SA, Vockley J, Vinks AA, Dong M, Diaz GA, McCandless SE, et al
For example, semaglutide patients commonly experience sagging facial skin (Ozempic Face) which may necessitate dermal fillers to compensate for lost volume.
reports honoraria and/or consulting fees from AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi-Sankyo, Mochida, Novartis and Novo Nordisk